🔎 Trials Near Me

Home › Sarcoma ng Malambot na Tisyu › Ohio › Columbus

Pag-aaral pangklinika para sa Sarcoma ng Malambot na Tisyu sa Columbus, OH

Isang pag-aaral para sa Sarcoma ng Malambot na Tisyu ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Nagre-recruitPhase 1/2
  • Nationwide Children's Hospital, Columbus
Edad 12 hanggang 40 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07725380

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • at 8 pa
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Nagre-recruitPhase 3
  • The James Cancer Hospital and Solove Research Institute, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06263231

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Nagre-recruitObservasyonal na pag-aaral
  • OSU James Hospital, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Nagre-recruitPhase 1/2
  • Ohio State University, Columbus
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06710756

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Nagre-recruitPhase 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Nagre-recruitObservasyonal na pag-aaral
  • Ohio State University, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 11, 2026 · NCT02677961

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Nagre-recruitPhase 1/2
  • Nationwide Children's Hospital, Columbus
Edad 2 hanggang 30 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT05734066

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

Nagre-recruit
  • Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT06500065

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT06943521

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Nagre-recruitPhase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2025 · NCT06528769

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Nagre-recruitPhase 2
  • Nationwide Children's Hospital, Columbus
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Nagre-recruitObservasyonal na pag-aaral
  • The Ohio State University, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 12, 2019 · NCT03838718

Pag-aaral para sa Sarcoma ng Malambot na Tisyu sa ibang lungsod

Iba pang pag-aaral sa Columbus

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.